Patents Assigned to KTB Tumorforschungsgesellschaft MBM
  • Receptor and antigen targeted prodrug
    Patent number: 9216228
    Abstract: The present invention relates to a prodrug which comprises at least one pharmaceutically and/or diagnostically active compound bound by a cleavable linker, a receptor and/or antigen targeting moiety and a protein-binding moiety which is capable of binding to a carrier molecule.
    Type: Grant
    Filed: February 15, 2008
    Date of Patent: December 22, 2015
    Assignee: KTB Tumorforschungsgesellschaft MBM
    Inventor: Felix Kratz